Categories: News

Etiqa pledges to support healthcare personnel in Singapore with free COVID-19 benefit including personal accident cover

SINGAPORE – Media OutReach – 6 August 2020 – Local insurer Etiqa
announced its support for healthcare personnel in Singapore amid Phase Two of
the city state’s reopening. All staff working in the local healthcare sector
are eligible for a complimentary 3-month Special
COVID-19 Benefit
of up to S$52,000 in case of diagnosis of COVID-19 and
Personal Accident cover.

 

With more activities resumed in Phase Two,
Singapore faces the risk of a second COVID-19 wave. This support initiative is
launched timely to acknowledge the continued efforts of healthcare personnel,
and reaffirms Etiqa’s commitment to stand united in the nation’s fight against
coronavirus.

 

“Healthcare staff and support workers face a
higher risk as they stay at the forefront to help others at the height of the
coronavirus pandemic. With this Special
COVID-19 Benefit with Personal Accident cover
, we hope to reduce any
anxiety or mental stress that our healthcare personnel or their families may
feel as our nation continues in our fight against the coronavirus,” said Yip
Kim Chee, interim CEO of Etiqa Insurance Singapore.

 

Mr Yip added, “This is Etiqa’s way of showing
gratitude and support to our healthcare personnel in a tangible way.”

 

Besides the Financial Assistance Benefit, the
complimentary Personal Accident cover offers S$50,000 in case of accidental
death and permanent disability, and a cash payout of S$100 per day of
hospitalisation, up to 10 days in Singapore.

 

Interested
healthcare personnel can easily apply for the Special COVID-19 Benefit with Personal Accident cover at Etiqa’s
website or via the Lions of Healthcare initiative.  For more information, please visit https://bit.ly/3ftmx2R

 

Terms apply.
Protected up to specified limits by SDIC.

About Etiqa Insurance Pte. Ltd. (Etiqa Singapore)

A Singapore
Insurance Company with Asian and International Expertise


Protecting customers since 1961, Etiqa is a licensed
life and general insurance company registered in the Republic of Singapore. We
are regulated by the Monetary Authority of Singapore (MAS) and governed by the
Insurance Act.

With a comprehensive suite
of protection, savings, retirement and legacy planning solutions, we are committed to helping our customers plan for a better
future. Rated ‘A’ by Fitch in April 2020 for our financial strength and stable
outlook, we humanise insurance by placing people over policies.

Etiqa is owned by Maybank Ageas Holdings Berhad, a
joint venture company that combines local market knowledge with international
insurance expertise. The company is 69% owned by Maybank, the fourth largest
banking group in Southeast Asia, and 31% by Ageas, an international insurance
group with footprints across 16 countries and a heritage that spans over 190
years. 

Miscw.com

Recent Posts

China Focus: Technology sows seeds of hope in combating desertification

HOHHOT, CHINA - Media OutReach Newswire - 23 December 2024 - China's National Forestry and…

10 hours ago

Novautek Honored with the “Outstanding SME ESG and Business Performance Award”

HONG KONG SAR - EQS Newswire - 23 December 2024 - Novautek Autonomous Driving Limited…

12 hours ago

V-GREEN and Xanh SM Indonesia sign MoU with Lippo for comprehensive green ecosystem in Indonesia

JAKARTA, INDONESIA - Media OutReach Newswire - 23 December 2024 - V-GREEN and PT Xanh…

12 hours ago

Molex Anticipates Steady Growth in High-Speed Connectivity in 2025, Driving Electronics Design Innovations Across Diverse Industry Sectors

Increase in opportunities predicted for high-speed optical transceivers and miniaturized connectivity solutions to address data-intensive…

14 hours ago

Celebrating 25 Years of Excellence: DYXnet Embarks the New Chapter of Digital Transformation

HONG KONG SAR - Media OutReach Newswire - 23 December 2024 - DYXnet, a wholly-owned…

15 hours ago

The Top 10 Best Places to Work in Egypt for 2024 revealed

CAIRO, EGYPT - Media OutReach Newswire - 23 December 2024 - Eand, Novo Nordisk, BSH,…

17 hours ago